Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 256 of 1,261

  1. US 11369692

    Materials and methods for treatment of Duchenne Muscular Dystrophy

    Vertex Pharmaceuticals Incorporated · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  2. US 11369716

    Reparative cell isolation and delivery

    The Board of Regents of the University of Texas System · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  3. US 11369697

    Liposome nanoparticles for tumor magnetic resonance imaging

    United Kingdom Research and Innovation · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  4. US 11369688

    Hybrid telodendrimers

    The Regents of the University of California · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  5. US 11369683

    Systems and methods for targeted imaging and ablation of cardiac cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  6. US 11369675

    Broadly protective inactivated influenza virus vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  7. US 11370757

    Photocleavable nitroindoline-based crosslinkers

    The Board of Regents of the University of Texas System · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  8. US 11372008

    Blood factor monitoring assay and uses thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  9. US 11369657

    Small molecule polypeptide for preventing and restraining inflammation and application of same

    SHANGHAI FIRST PEOPLE'S HOSPITAL · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  10. US 11369644

    Microbial consortia

    The Regents of the University of California · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  11. US 11372002

    Assays for determining plasma kallikrein system biomarkers

    Takeda Pharmaceutical Company Limited · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  12. US 11369588

    NADPH production by the 10-formyl-THF pathway, and its use in the diagnosis and treatment of disease

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  13. US 11369575

    PPARα agonist compositions and methods of use

    The Board of Regents of the University of Oklahoma · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  14. US 11369622

    Methods and compounds to inhibit enveloped virus release

    Northwestern University · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  15. US 11370843

    High affinity antibodies to human IL-6 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  16. US 11371024

    Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  17. CA 3201259

    MASITINIB POUR LE TRAITEMENT DE LA MALADIE D'ALZHEIMER

    AB SCIENCE [FR] · Granted Jun 23, 2022 · Expires Jun 18, 2042

    granted

  18. WO 2022131944

    RÉGIMES DE TRAITEMENT DE LA MALADIE DE PARKINSON IDIOPATHIQUE PRÉCOCE

    BIAL PORTELA & CA SA [PT] · Granted Jun 23, 2022 · Expires Jun 18, 2042

    granted

  19. US 2022193051

    TREATMENT OF MIGRAINE

    ALLERGAN PHARMACEUTICALS INTERNTIONAL LTD [IE] · Granted Jun 23, 2022 · Expires Jun 18, 2042

    granted

  20. US 11365265

    Anti-C5 antibody combinations and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted

  21. US 11364251

    Pharmaceutical formulation

    Semnur Pharmaceuticals, Inc. · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted

  22. US 11364245

    Use of reboxetine to treat narcolepsy

    AXSOME THERAPEUTICS, INC. · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted

  23. US 11365189

    Heterocyclic inhibitors of tyrosine kinase

    The Board of Regents of the University of Texas System · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted

  24. US 11364266

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.